Lance Alstodt, President, CEO, COB at BioRestorative Therapies, Inc. (BRTX), bought 200 shares at $3.92 ($790) on 2022-06-13, disclosed to the SEC on 2022-06-14.
Open-market purchase of $790 BRTX by President, CEO, COB. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.92 | 100 | $392 | 49.6% |
| 2 | $3.98 | 100 | $398 | 50.4% |
| Total | $3.95 avg | 200 | $790 | 100% |
| Filing → |
| BRTX | BUY | 2023-09-06 | $6K | — | Filing → |
| BRTX | BUY | 2023-07-25 | $10K | — | Filing → |
| BRTX | BUY | 2023-02-02 | $1K | — | Filing → |